Russia sees antidepressant sales triple amid war and repression

english.elpais.com

Russian antidepressant sales have tripled since 2019, exceeding pandemic levels due to the ongoing war, economic crisis, and political repression. Sales grew 36% in 2025, reaching 22.3 million packages, indicating a greater reliance on these medications than during the COVID-19 crisis. The war's impact on daily life appears more significant than the pandemic, with over 160,000 documented soldier deaths and estimated total losses reaching 352,000.


With a significance score of 5.4, this news ranks in the top 0.8% of today's 28772 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Russia sees antidepressant sales triple amid war and repression | News Minimalist